Global Biologics Outsourcing Formulation Services Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Biologics Outsourcing Formulation Services Market Insights, Forecast to 2034
Market Analysis and InsightsGlobal Biologics Outsourcing Formulation Services Market
Global Biologics Outsourcing Formulation Services market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Biologics Outsourcing Formulation Services industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Biologics Outsourcing Formulation Services key companies include AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International, GenScript, Merck, Lonza Group, Catalent, Innovent Biologics and Syngene, etc. AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Biologics Outsourcing Formulation Services were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Biologics Outsourcing Formulation Services market and estimated to attract more attentions from industry insiders and investors.
Biologics Outsourcing Formulation Services can be divided into Analytical Testing, Process Development, Cell Development and cGMP Manufacturing, etc. Analytical Testing is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Biologics Outsourcing Formulation Services is widely used in various fields, such as Stem Cell Research, Vaccine Development, Tissue Related Products Development and Others, etc. Stem Cell Research provides greatest supports to the Biologics Outsourcing Formulation Services industry development. In 2022, global % revenue of Biologics Outsourcing Formulation Services went into Stem Cell Research filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Biologics Outsourcing Formulation Services market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biologics Outsourcing Formulation Services market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
AtbbVie
Thermo Fisher Scientific
Boehringer Ingelheim International
GenScript
Merck
Lonza Group
Catalent
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Abzena
Adimab
Segment by Type
Analytical Testing
Process Development
Cell Development
cGMP Manufacturing
Others
Stem Cell Research
Vaccine Development
Tissue Related Products Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biologics Outsourcing Formulation Services introduction, etc. Biologics Outsourcing Formulation Services Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Biologics Outsourcing Formulation Services
Chapter 13Methodology and Data Sources adopted by MRAResearch
Global Biologics Outsourcing Formulation Services market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Biologics Outsourcing Formulation Services industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Biologics Outsourcing Formulation Services key companies include AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International, GenScript, Merck, Lonza Group, Catalent, Innovent Biologics and Syngene, etc. AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Biologics Outsourcing Formulation Services were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Biologics Outsourcing Formulation Services market and estimated to attract more attentions from industry insiders and investors.
Biologics Outsourcing Formulation Services can be divided into Analytical Testing, Process Development, Cell Development and cGMP Manufacturing, etc. Analytical Testing is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Biologics Outsourcing Formulation Services is widely used in various fields, such as Stem Cell Research, Vaccine Development, Tissue Related Products Development and Others, etc. Stem Cell Research provides greatest supports to the Biologics Outsourcing Formulation Services industry development. In 2022, global % revenue of Biologics Outsourcing Formulation Services went into Stem Cell Research filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Biologics Outsourcing Formulation Services market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biologics Outsourcing Formulation Services market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
AtbbVie
Thermo Fisher Scientific
Boehringer Ingelheim International
GenScript
Merck
Lonza Group
Catalent
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Abzena
Adimab
Segment by Type
Analytical Testing
Process Development
Cell Development
cGMP Manufacturing
Others
Segment by Application
Stem Cell Research
Vaccine Development
Tissue Related Products Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biologics Outsourcing Formulation Services introduction, etc. Biologics Outsourcing Formulation Services Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Biologics Outsourcing Formulation Services
Chapter 13Methodology and Data Sources adopted by MRAResearch